LONG COVID SYNDROME
Clinical trials for LONG COVID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LONG COVID SYNDROME trials appear
Sign up with your email to follow new studies for LONG COVID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets lingering COVID symptoms
Disease control Recruiting nowThis study is testing whether a drug called Anktiva is safe for people with Long COVID—persistent symptoms that continue after the initial infection has cleared. The trial will enroll 40 adults who have had bothersome Long COVID symptoms for at least 60 days. Researchers will clo…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Blood filter trial offers hope for debilitating long COVID fatigue
Disease control Recruiting nowThis study is testing a treatment called immunoadsorption for people with long COVID who have harmful antibodies in their blood. The treatment filters the blood to remove these antibodies. About 70 participants will be randomly assigned to receive either the real blood-filtering …
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
MRI scans could predict your future heart health
Knowledge-focused Recruiting nowThis study aims to see if a special type of MRI scan can better predict who is at risk for future heart problems like heart failure or heart attacks. It will enroll 6,000 adults who are generally healthy and have no known heart disease. Researchers will use the MRI scans to look …
Matched conditions: LONG COVID SYNDROME
Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC